Диссертация (1140225), страница 19
Текст из файла (страница 19)
Clin Biochem. 2018; 51:3847. doi: 10.1016/j.clinbiochem.2017.05.001.104. Zakharova EV, Stolyarevich ES, Vorobyeva OA, Nikitin EA Combinedimmunoglobulin G kappa nephropathy: Monoclonal immunoglobulindeposition disease and proximal tubulopathy: monoclonal gammopathy ofrenal significance or smoldering multiple myeloma? Case report and review121ofliterature.IntegrCancerSciTherap.2017;4(1):1-9.doi:10.15761/ICST.1000225.105. Zand L, Kattah A, Fervenza FC, Smith RJ, Nasr SH, Zhang Y, Vrana JA,Leung N, Cornell LD, Sethi S. C3 glomerulonephritis associated withmonoclonal gammopathy. Am. J.
Kidney Dis. 2013; 62 (3): 506—14.doi:10.1053/j.ajkd.2013.02.370.106. Zhang Y, Meyer NC, Wang K, Nishimura C, Frees K, Jones M, Katz LM,Sethi S, Smith RJ. Causes of alternative pathway dysregulation in densedeposit disease. Clin J Am Soc Nephrol. 2012; 7(2):265-74. doi:10.2215/CJN.07900811.107. ZhuL,HerreraGA,Murphy-UllrichJE,HuangZQ,SandersPW.Pathogenesis of glomerulosclerosis in light chain deposition disease. Rolefor transforming growth factor-beta. Am J Pathol. 1995; 147(2):375-85.108. Zingone A, Kuehl M. Pathogenesis of monoclonal gammopathy ofundetermined significance (MGUS) and progression to multiple myeloma.Semin Hematol. 2011; 48(1):4-12. doi: 10.1053/j.seminhematol.2010.11.003..
![](https://s.studizba.com/z.php?f=/templates/si/i/noavatar.png&w=100&h=100&t=1"){kind=avatar}
